Tau pathology reduction with SM07883, a novel, potent, and selective oral DYRK1A inhibitor: A potential therapeutic for Alzheimer's disease.
Saved in:
| Title: | Tau pathology reduction with SM07883, a novel, potent, and selective oral DYRK1A inhibitor: A potential therapeutic for Alzheimer's disease. |
|---|---|
| Authors: | Melchior, Benoît1 (AUTHOR) benoit@samumed.com, Mittapalli, Gopi Kumar1 (AUTHOR), Lai, Carolyn1 (AUTHOR), Duong‐Polk, Karen1 (AUTHOR), Stewart, Joshua1 (AUTHOR), Güner, Bora1 (AUTHOR), Hofilena, Brian1 (AUTHOR), Tjitro, Amanda1 (AUTHOR), Anderson, Scott D.1 (AUTHOR), Herman, David S.1 (AUTHOR), Dellamary, Luis1 (AUTHOR), Swearingen, Christopher J.1 (AUTHOR), Sunil, K.C.1 (AUTHOR), Yazici, Yusuf1 (AUTHOR) |
| Source: | Aging Cell. Oct2019, Vol. 18 Issue 5, pN.PAG-N.PAG. 1p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
